AKT1 and brain infarction: The results showed that salidroside could reduce the expression of microglial markers, CD44 and CD14, in the cerebral infarction surrounding area; increase the ratio of p-Akt to total Akt; and up-regulate the expression of HIF-α, thus reducing inflammatory infiltration in ischemic brain tissue [106,107].